Gryphon Financial Partners LLC Vertex Pharmaceuticals Inc Transaction History
Gryphon Financial Partners LLC
- $736 Million
- Q3 2024
A detailed history of Gryphon Financial Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 1,869 shares of VRTX stock, worth $752,646. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,869
Previous 1,553
20.35%
Holding current value
$752,646
Previous $727,000
19.53%
% of portfolio
0.12%
Previous 0.11%
Shares
28 transactions
Others Institutions Holding VRTX
# of Institutions
1,725Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.8 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.33 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.58 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.76 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.63 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $103B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...